Bigul

Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with sub-clause (7A) of Clause A in Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that M/s. Piyush J. Shah & Co., Chartered Accountants, vide its letter dated October 14, 2020 have resigned as Statutory Auditors' of the Company with effect from October 14, 2020 for the reasons stated in the Annexure. A copy of the stated Resignation and Annexure-A, as envisaged in SEBI Circular No. CIR/CFD/CMD1/114/2019 dated October 18, 2019, as received from the M/s. Piyush J. Shah & Co., are attached with this intimation as an Annexure.
15-10-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances- Compliance Certificate For The Period Ended September, 2020

We hereby certify that all activities in relation to both physical and electronic share transfer facilities are maintained by our Registrar and Share Transfer Agent i.e. Bigshare Services Private Limited (SEBI Reg. No. INR000001385) having its Office at A/802, Samundra Complex, Near Klassic Gold, Girish cold drink, C.G. Road, Ahmedabad-380009, Gujarat. Further, we confirm that Bigshare Services Private Limited is registered with Securities and Exchange Board of India to act as Registrar and Transfer Agents. Further, pursuant to Regulation 7(3) of the LODR Regulations, we are submitting the compliance certificate for the half year ended on 30th September, 2020 i.e. for the period from April 1, 2020 to September 30, 2020. We request you to take this certificate on record. Thanking You
12-10-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Shareholding for the Period Ended September 30, 2020

Indo Us Bio-Tech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
12-10-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances-Submission Of Certificate Under Regulation 40(9) And 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 30Th September, 2020

We are submitting herewith the certificate under Regulation 40(9) & 40(10) of the SEBI (LODR) Regulation 2015 obtained from Practicing Company Secretary for the half year ended on 30th September, 2020. Kindly take the same on your record. Thanking you,
08-10-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We herewith enclose a Certificate dated 5th October, 2020 under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter/half year ended 30th September, 2020 received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent of our company. Thanking you,
07-10-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Statement Of Investor Complaints For The Quarter Ended September 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dimpy JoshiDesignation :- Company Secretary and Compliance Officer
07-10-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Indo Us Bio-Tech Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
03-10-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed the details of voting results with respect to 16"Annual General Meeting of the Company held on Wednesday, September 30, 2020 at 10:30 a.m. at through electronic mode (video conference or other audio visual means) as per the format prescribed. Also, please find enclosed, for your records the report issued by the Scrutinizer i.e. Mr. AMRISH GANDHI, FCS Proprietor of M/ s. AMRISH GANDHI & Associates, Company Secretaries We request you to take the aforesaid on records.
01-10-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Closure of Trading Window

This is to inform you that in terms of Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company, pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time, read with BSE vide circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019, the Trading Window for dealing in the Securities of the Company will remain closed from 1st ,October, 2020 till 48 hours after announcement / declaration of unaudited financial results for the half year ended on 30th September, 2020.
30-09-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Revised Annual Report

In continuation of our letter dated September 7, 2020 regarding 'Intimation regarding the sixteenth (16) Annual General Meeting ('AGM') of the Company, Annual Report & E-Voting', we hereby submit the revised copy of the Annual Report of Indo Us Bio Tech Limited for FY20 rectifying the enclosing herewith mistake in the Director's Report.
30-09-2020
Next Page
Close

Let's Open Free Demat Account